Sulfafurazole
Not to be confused with sulfadiazine.
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| MedlinePlus | a601049 |
| Pregnancy category |
|
| Legal status |
|
| Routes of administration | Oral |
| Pharmacokinetic data | |
| Excretion | Excreted unchanged in urine |
| Identifiers | |
| CAS Number |
127-69-5 |
| ATC code | J01EB05 S01AB02 QJ01EQ05 |
| PubChem | CID 5344 |
| DrugBank |
DB00263 |
| UNII |
740T4C525W |
| KEGG |
D00450 |
| ChEMBL |
CHEMBL453 |
| Chemical data | |
| Formula | C11H13N3O3S |
| Molar mass | 267.30 g/mol |
| |
| Physical data | |
| Melting point | 194 °C (381 °F) |
| | |
Sulfafurazole (INN, also known as sulfisoxazole) is a sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of Gram-negative and Gram-positive organisms. It is sometimes given in combination with erythromycin (see erythromycin/Sulfafurazole) or phenazopyridine. It is used locally in a 4% solution or ointment.
Synthesis

See also
External links
- Sulfisoxazole at the US National Library of Medicine Medical Subject Headings (MeSH)
- MedlinePlus DrugInfo medmaster-a601049
- MedlinePlus DrugInfo medmaster-a601115
- DDB 30455
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Monday, November 30, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
